Chat with us, powered by LiveChat






IONTOX to Present at the 10th World Congress on Alternatives and Animals in the Life Sciences


On Thursday, August 24th at 10:00 AM IONTOX president Jim Mckim, will participate in an oral presentation at the 10th World Congress on Alternatives and Animals in the Life Sciences with our partner company Qualyst Transporter Solutions on new methods for predicting drug-induced liver toxicity and integrated multiple organ test systems. Presentation Information: Abstract Number: […]


Read more


Have a need for in vitro toxicity testing? Will you be at SOT?


From Saturday, March 11th to March 15th IONTOX founder Toxicologist Jim Mckim, and Director of Laboratory Services Nick Hibbard will be at the Annual Society of Toxicology meeting in Baltimore, Maryland. IONTOX, is a CRO specializing the development of new in vitro models for new molecular entity testing. The company’s latest development includes a Multiple Organ […]


Read more

The Importance Of Removing Antibiotics And Antifungals From Media Used In Cell Culture.


Three common additives to cell culture media are the beta-lactam family of antibiotics (penicillin), aminoglycosides family of antibiotics (streptomycin), and the antifungal family polyene macrolides (amphotericin B). Penicillin, streptomycin, andamphotericin B are often added to culture media to prevent unwanted contamination in the culture. However, overuse of antibiotics and antifungals can mask serious problems including mycoplasma […]


Read more

IONTOX and British American Tobacco announce collaboration to develop Lung-Liver-Lung model


24 November 2016 US-based biotech company IONTOX and British American Tobacco have entered into a collaboration to develop a lung-liver-lung model with a simulated blood system to study the impact of tobacco and nicotine products on lung health. Cigarette smoking is associated with a number of diseases that can impact the lung, such as cancer […]


Read more